Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: A0A3Q8I9T1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 217 | 221 | PF00656 | 0.478 |
CLV_NRD_NRD_1 | 189 | 191 | PF00675 | 0.571 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.471 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.763 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.439 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.473 |
DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.412 |
DOC_PP1_RVXF_1 | 258 | 264 | PF00149 | 0.504 |
DOC_PP1_RVXF_1 | 46 | 52 | PF00149 | 0.530 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.541 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.548 |
LIG_14-3-3_CanoR_1 | 286 | 296 | PF00244 | 0.586 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.431 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.388 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.508 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.434 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.431 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.491 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.533 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.430 |
LIG_FHA_1 | 252 | 258 | PF00498 | 0.377 |
LIG_FHA_1 | 293 | 299 | PF00498 | 0.578 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.452 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.388 |
LIG_Integrin_isoDGR_2 | 292 | 294 | PF01839 | 0.477 |
LIG_LIR_Apic_2 | 147 | 153 | PF02991 | 0.396 |
LIG_LIR_Apic_2 | 93 | 98 | PF02991 | 0.346 |
LIG_LIR_Gen_1 | 193 | 202 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 303 | 310 | PF02991 | 0.496 |
LIG_LIR_Gen_1 | 44 | 53 | PF02991 | 0.484 |
LIG_LIR_LC3C_4 | 133 | 138 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 193 | 197 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.432 |
LIG_PCNA_yPIPBox_3 | 228 | 242 | PF02747 | 0.379 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.467 |
LIG_SH2_NCK_1 | 95 | 99 | PF00017 | 0.520 |
LIG_SH2_SRC | 194 | 197 | PF00017 | 0.359 |
LIG_SH2_STAP1 | 194 | 198 | PF00017 | 0.358 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.473 |
LIG_SH3_1 | 69 | 75 | PF00018 | 0.479 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.460 |
LIG_SUMO_SIM_anti_2 | 215 | 221 | PF11976 | 0.447 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.495 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.602 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.515 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.505 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.485 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.467 |
MOD_Cter_Amidation | 188 | 191 | PF01082 | 0.474 |
MOD_GlcNHglycan | 16 | 20 | PF01048 | 0.543 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.523 |
MOD_GlcNHglycan | 234 | 238 | PF01048 | 0.545 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.561 |
MOD_GlcNHglycan | 280 | 283 | PF01048 | 0.570 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.389 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.484 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.683 |
MOD_GSK3_1 | 288 | 295 | PF00069 | 0.694 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.430 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.443 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.547 |
MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.484 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.463 |
MOD_N-GLC_2 | 108 | 110 | PF02516 | 0.424 |
MOD_N-GLC_2 | 159 | 161 | PF02516 | 0.442 |
MOD_N-GLC_2 | 262 | 264 | PF02516 | 0.262 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.613 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.507 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.449 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.443 |
MOD_PIKK_1 | 154 | 160 | PF00454 | 0.438 |
MOD_PIKK_1 | 27 | 33 | PF00454 | 0.575 |
MOD_PKA_1 | 190 | 196 | PF00069 | 0.529 |
MOD_PKA_1 | 286 | 292 | PF00069 | 0.771 |
MOD_Plk_1 | 132 | 138 | PF00069 | 0.386 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.525 |
MOD_Plk_1 | 242 | 248 | PF00069 | 0.465 |
MOD_Plk_1 | 41 | 47 | PF00069 | 0.466 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.428 |
MOD_Plk_4 | 170 | 176 | PF00069 | 0.477 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.492 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.395 |
MOD_SUMO_for_1 | 153 | 156 | PF00179 | 0.433 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.482 |
MOD_SUMO_rev_2 | 121 | 126 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 281 | 289 | PF00179 | 0.650 |
TRG_DiLeu_BaEn_1 | 121 | 126 | PF01217 | 0.434 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.533 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.578 |
TRG_ENDOCYTIC_2 | 305 | 308 | PF00928 | 0.482 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0V1 | Leptomonas seymouri | 59% | 100% |
A0A0S4KDQ4 | Bodo saltans | 43% | 100% |
A0A1X0NQ77 | Trypanosomatidae | 46% | 99% |
A0A381MFS8 | Leishmania infantum | 85% | 100% |
A0A3R7N2S2 | Trypanosoma rangeli | 45% | 97% |
A0A3S7WSX7 | Leishmania donovani | 85% | 100% |
A4H7J8 | Leishmania braziliensis | 53% | 100% |
C9ZT43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 94% |
E9AGK8 | Leishmania infantum | 97% | 100% |
E9APN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
E9APN3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
E9APN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 100% |
Q4QFU5 | Leishmania major | 86% | 100% |
Q4QFU6 | Leishmania major | 79% | 100% |
V5BD72 | Trypanosoma cruzi | 43% | 97% |